These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

785 related items for PubMed ID: 17174648

  • 1. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B, Derntl M, Marx M, Lercher P, Gössinger HD.
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [Abstract] [Full Text] [Related]

  • 2. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
    Al Chekakie MO, Akar JG, Wang F, Al Muradi H, Wu J, Santucci P, Varma N, Wilber DJ.
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
    [Abstract] [Full Text] [Related]

  • 3. The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females.
    Patel D, Mohanty P, Di Biase L, Wang Y, Shaheen MH, Sanchez JE, Horton RP, Gallinghouse GJ, Zagrodzky JD, Bailey SM, Burkhardt JD, Lewis WR, Diaz A, Beheiry S, Hongo R, Al-Ahmad A, Wang P, Schweikert R, Natale A.
    Europace; 2010 Mar; 12(3):322-30. PubMed ID: 20064822
    [Abstract] [Full Text] [Related]

  • 4. Frequency of recurrence of atrial fibrillation within 48 hours after ablation and its impact on long-term outcome.
    Richter B, Gwechenberger M, Socas A, Marx M, Gössinger HD.
    Am J Cardiol; 2008 Mar 15; 101(6):843-7. PubMed ID: 18328850
    [Abstract] [Full Text] [Related]

  • 5. Statins improve surgical ablation outcomes for atrial fibrillation in patients undergoing concomitant cardiac surgery.
    Kuhn EW, Liakopoulos OJ, Borys MJ, Haldenwang PL, Strauch JT, Madershahian N, Choi YH, Wahlers T.
    Interact Cardiovasc Thorac Surg; 2010 Jul 15; 11(1):24-8. PubMed ID: 20378695
    [Abstract] [Full Text] [Related]

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 15; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 7. Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins.
    Chae YK, Valsecchi ME, Kim J, Bianchi AL, Khemasuwan D, Desai A, Tester W.
    Cancer Invest; 2011 Nov 15; 29(9):585-93. PubMed ID: 21936625
    [Abstract] [Full Text] [Related]

  • 8. Is inducibility of atrial fibrillation after radio frequency ablation really a relevant prognostic factor?
    Richter B, Gwechenberger M, Filzmoser P, Marx M, Lercher P, Gössinger HD.
    Eur Heart J; 2006 Nov 15; 27(21):2553-9. PubMed ID: 17038349
    [Abstract] [Full Text] [Related]

  • 9. Impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the long-term outcome after pulmonary vein isolation for paroxysmal atrial fibrillation.
    Klemm HU, Heitzer T, Ruprecht U, Meinertz T, Ventura R.
    Cardiology; 2010 Nov 15; 117(1):14-20. PubMed ID: 20881389
    [Abstract] [Full Text] [Related]

  • 10. Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.
    Ozaydin M, Varol E, Türker Y, Peker O, Erdoğan D, Doğan A, Ibrişim E.
    Anadolu Kardiyol Derg; 2010 Apr 15; 10(2):137-42. PubMed ID: 20382613
    [Abstract] [Full Text] [Related]

  • 11. [Upstream therapy of atrial fibrillation in patients with heart failure].
    Alboni P, Gianfranchi L, Pacchioni F.
    G Ital Cardiol (Rome); 2009 Sep 15; 10(9):566-71. PubMed ID: 19891248
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
    Lip GY, Frison L, Grind M.
    J Intern Med; 2007 Jun 15; 261(6):577-86. PubMed ID: 17547713
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
    Zheng B, Kang J, Tian Y, Tang R, Long D, Yu R, He H, Zhang M, Shi L, Tao H, Liu X, Dong J, Ma C.
    Acta Cardiol; 2009 Jun 15; 64(3):335-40. PubMed ID: 19593943
    [Abstract] [Full Text] [Related]

  • 14. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
    Fazio G, Pizzuto C, Sutera L, Guttilla D, Di Gesaro G, Cascio C, Novo G, Assennato P, Novo S.
    Minerva Cardioangiol; 2007 Jun 15; 55(3):311-5. PubMed ID: 17534249
    [Abstract] [Full Text] [Related]

  • 15. ARBs, ACE-Is, or statins after catheter ablation of atrial fibrillation?
    Deneke T.
    J Cardiovasc Electrophysiol; 2007 Sep 15; 18(9):947-9. PubMed ID: 17666057
    [No Abstract] [Full Text] [Related]

  • 16. Does treatment with ACE inhibitors or angiotensin II receptor antagonists prevent atrial fibrillation after dual chamber pacemaker implantation?
    Williams SG, Connelly DT, Jackson M, Bennett A, Albouaini K, Todd DM.
    Europace; 2005 Nov 15; 7(6):554-9. PubMed ID: 16216757
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR, Romero B, Fernandez-Carbonero E, Sánchez-Casado E, Cubero JJ.
    J Renin Angiotensin Aldosterone Syst; 2009 Dec 15; 10(4):195-200. PubMed ID: 20026868
    [Abstract] [Full Text] [Related]

  • 18. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM, Sanoski CA, Spinler SA.
    Pharmacotherapy; 2009 Jan 15; 29(1):31-48. PubMed ID: 19113795
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Blockade of renin-angiotensin system: a supplementary treatment for circumferential pulmonary vein isolation in treating persistent atrial fibrillation.
    Dai SM, Zhang S, Chu JM, Guo YH, Chen KP, Yao Sy.
    Med Hypotheses; 2007 Jan 15; 69(4):767-72. PubMed ID: 17475415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.